Xolremdi Capsule, Gelatin Coated
Product Images NDC 83296-100

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Xolremdi (NDC 83296-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by X4 Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Xolremdi 01)

Chemical structure of mavorixafor, the active ingredient in XOLREMDI capsules. The diagram shows the arrangement of atoms and bonds in the molecule, including nitrogen-containing rings and an amino side chain.*

FDA Label Image

Figure 2 (Xolremdi 02)

A line graph comparing TAT_ANC hours over a 52-week period for XOLREMDI (mavorixafor) capsules versus placebo. The x-axis shows time points at weeks 0, 13, 26, 39, and 52, while the y-axis shows TAT_ANC in hours. The red solid line with triangles represents XOLREMDI, showing an increase up to week 13 then a gradual decline. The blue dashed line with circles represents placebo, showing relatively stable TAT_ANC values over time. Sample sizes for each group at each time point are noted below the x-axis.*

FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Label)

Label for XOLREMDI capsules containing 100 mg of mavorixafor. The label indicates an oral gelatin-coated capsule dosage form with 60 capsules per bottle. It includes storage instructions to refrigerate at 2°C to 8°C, a caution to swallow capsules whole without opening, and manufacturer information for X4 Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.